CD38 and B-cell chronic lymphocytic leukemia: The data obtained in the current study are nonconcordant with those reported by Khalifa et al. who demonstrated a significantly lower expression of miR-17-5p and CD38-negative and ZAP-70-negative group in CLL patients [34].